GlassScriptPhysician profile
Beth G Lafont
NPI 1073758421
$2,912.67
in general payments reported to CMS, 2019-2025
32 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $189 · 2021: $360 · 2022: $571 · 2023: $400 · 2024: $712 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,494.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $573.68 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $220.10 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $183.09 | 2022-2025 | |
| Astellas Pharma US INC | $159.46 | 2023-2025 | Veozah |
| Biogen, INC. | $147.59 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $144.52 | 2022-2023 | Twirla |
| Pfizer INC. | $132.58 | 2021-2024 | |
| Evofem Biosciences, INC. | $130.52 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.51 | 2019-2025 | |
| Therapeuticsmd, INC. | $123.69 | 2019-2021 | |
| Exact Sciences Corporation | $110.59 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $107.88 | 2019-2024 | Gardasil, Gardasil 9 |
| Shield Therapeutics INC | $104.24 | 2022-2025 | Accrufer |
| Hologic Sales and Service, LLC | $72.39 | 2021-2024 | Aptima |
| Organon LLC | $66.63 | 2022-2023 | Nexplanon |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $54.33 | 2020-2025 | Paragard T 380a |
| Duchesnay USA Incorporated | $50.56 | 2019 | |
| Mylan Pharmaceuticals INC. | $47.83 | 2021 | |
| Exeltis, USA INC. | $44.20 | 2024-2025 | Slynd |
| Vertical Pharmaceuticals, LLC | $35.50 | 2019-2020 | |
| Boston Scientific Corporation | $33.52 | 2023 | |
| Millicent US INC | $32.40 | 2024-2025 | Intrarosa |
| Optumhealth Care Solutions, LLC | $30.58 | 2023-2024 | Eitan Medical, Vivify Health Care Team Portal 001, Zyno Solutions |
| Minerva Surgical, INC | $30.00 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $27.92 | 2019 | |
| Scynexis, INC. | $25.45 | 2022 | |
| Becton, Dickinson and Company | $20.20 | 2024 | Bd Onclarity |
| Myovant Sciences INC. | $18.39 | 2021 | |
| Intuitive Surgical, INC. | $17.56 | 2024 | |
| Gynesonics, INC. | $13.40 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Lupin INC. | $13.00 | 2021 | |
| Allergan, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Lafont listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.